Zymvol

Reliable Enzyme Innovation

Barcelona, Spain · Founded 2017 · $3.3M raised

Headquarters
Barcelona
Employees
11–50
Founded
2017
Business Model
B2B
Website
zymvol.com
Total Funding
$3.3M
Last Round
$3.3M SeedFeb 2025
Rounds
1

About

Zymvol Biomodeling is a Barcelona-based biotech company founded in 2017 that uses bioinformatics, molecular modelling, and AI to accelerate enzyme discovery and engineering for industrial applications. Its mission is to make custom-made enzymes accessible for any industry, turning green chemistry into the default option for manufacturers worldwide. Zymvol's computational platform can evaluate enzymatic routes across 15-20 molecules simultaneously and reduce enzyme discovery timelines from 18 months to as few as 6 months. The company is ISO 9001 and ISO 27001 certified, backed by EU funding and investors including Elaia Partners, and has delivered enzymes to customers in pharma, specialty chemicals, and sustainable materials sectors.

Summary

Zymvol is a Biotech company based in Barcelona, Spain, founded in 2017. It has raised $3.3M in total across 1 round, most recently a $3.3M Seed round in Feb 2025. Investors include Faber Ventures, Elaia and Übermorgen.

Tech & App Stack

5 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundFeb 2025
$3.3M

Investors

Similar Companies